The most common medical problems in brain tumor patients include the management of
seizures, peritumoral edema, medication side effects, venous thromboembolism (VTE) …

Congenital prothrombotic conditions in pediatric patients include factor V Leiden mutation,
prothrombin gene mutation, and deficiencies of antithrombin III, protein C, and protein S …

OBJECTIVE Venous thromboembolism (VTE) is a common and potentially life-threatening
complication. The risk of serious hemorrhagic complications when starting chemical …

Purpose The prevalence and risk factors for thromboembolism (TE) in children with cancer
are largely unknown. This retrospective cohort study aims to determine the epidemiology of …

Malignant gliomas are associated with a very high risk of venous thromboembolism (VTE).
While many clinical risk factors have previously been described in brain tumor patients, the …

Background Venous thrombolism (VTE) is a significant cause of morbidity for surgical
patients. Comparative risk across major procedures is unknown. Methods Retrospective …

Objective To analytically discuss some protocols in Deep vein thrombosis (DVT)/pulmonary
Embolism (PE) prophylaxis currently use in Neurosurgical Departments around the world …

There are emerging linkages between biological and genetic aspects of cancer progression
and the mechanisms of cancer-associated thrombosis. It is argued that reciprocal influences …

Brain tumors can present challenging medical problems. Seizures, peritumoral edema,
venous thromboembolism, fatigue, and cognitive dysfunction can complicate the treatment of …

Purpose Adults with malignancy are at increased risk for venous thromboembolic events
(TEs). However, data in children and young adults with cancer are limited. Patients and …